Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Brian F. Gilmore, MD

Advertisement

Articles by Brian F. Gilmore, MD

How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?

ByRamiro Jose Madden-Fuentes, MD,Bridget F. Koontz, MD,Michael R. Harrison, MD,Daniel J. George, MD,Brittany Davidson, MD,Brian F. Gilmore, MD,Judd W. Moul, MD,Christopher Mantyh, MD,Andrew C. Peterson, MD
April 15th 2017

Sexual and urinary morbidities resulting from treatment of pelvic malignancies are common. Awareness of these complications is critical in order to properly counsel patients regarding potential side effects and to facilitate prompt diagnosis and management.

Advertisement

Latest Updated Articles

  • How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?
    How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?

    April 15th 2017



Advertisement
Advertisement

Trending on CancerNetwork

1

FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer

2

FDA Clears Triton Robotic Endoscopy System for Colon Procedures

3

Japan Approves T-DXd Combo and Dato-DXd for First-Line Metastatic Breast Cancer

4

Fixed-Duration Combinations and MRD-Guided Therapy as Emerging Priorities in CLL

5

Subcutaneous Amivantamab Combo is a “Clear” New Standard in EGFR+ NSCLC

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us